The global Plant-Based Vaccines Market is estimated to be valued at US$ 43.7 million in 2021 and is projected to reach US$ 49.9 million by 2028, with a CAGR of XX% during the forecast period, as stated in a new report by Coherent Market Insights. Plant-based vaccines are derived from plants, offering numerous advantages such as cost-effectiveness, scalability, safety, and ease of production. ... Read more
Plant-based vaccines utilize plants as bioreactors for antigens which can help stimulate human immune response. The key advantages of plant-based vaccine production are possibility of low-cost oral delivery, ease of scalability, thermostability without any cold chain requirement and rapid production. With rising prevalence of infectious diseases and emerging need for effective vaccination programs globally, alternative platforms for vaccine manufacturing are gaining prominence.
